Biology of the gonadotropin-releasing hormone system in gynecological cancers

European Journal of Endocrinology

Volumn 146, Issue 1, 2002, Pages 1-14

  Gründker, Carsten ^a   Günthert, Andreas R ^a   Westphalen, Silke ^a   Emons, Günter ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN RECEPTOR; GROWTH FACTOR RECEPTOR; HORMONE ANALOG; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; AUTOCRINE EFFECT; BIOLOGY; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME ACTIVATION; GYNECOLOGIC CANCER; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS; MALIGNANT NEOPLASTIC DISEASE; MITOGENESIS; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036164170     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460001     Document Type: Review

References (116)

1. Hypothalamic hormones from neuroendocrinology to cancer therapy
2. Expression and signal transduction pathways of gonadotropin-releasing hormone receptors
3. Mechanisms mediating multiple physiological responses to gonadotropin-releasing hormone
4. The use of luteinizing hormone-releasing hormone agonists and antagonists in gynecological cancers
5. Tight coupling of gonadotropin-releasing hormone receptor to stimulated phosphoinositide turnover and antigonadotropic action in granulosa cells
6. Intracellular signaling in the gonads
7. GnRH receptors: Structure and signal transduction pathways
8. Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma
9. Gonadotropin-releasing hormone gene expression in MDA-MB-231 and ZR-75-71 breast carcinoma cell lines
10. Extrapituitary actions of gonadotropin-releasing hormone
11. The secretion of human chorionic gonadotropin as well as the α- and β-messenger ribonucleic acid levels are stimulated by exogenous gonadoliberin pulses applied to first trimester placenta in a superfusion culture system
12. Expression of human gonadotropin-releasing hormone receptor gene in placenta and its functional relationship to human chorionic gonadotropin secretion
13. Human placental gonadotropin-releasing hormone (GnRH) binding sites. I. Characterization, properties and ligand specifity
14. Human placental gonadotropin-releasing hormone (GnRH) binding sites: III. Changes in GnRH binding levels with stage of gestation
15. GnRH receptor mRNA expression by in situ hybridization in the primate pituitary and ovary
16. Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells
17. Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells
18. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro
19. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro
20. Gonadotropin-releasing hormone (GnRH) agonist induces down-regulation of the CD3+CD25+ lymphocyte subpopulation in peripheral blood
21. Presence of luteinizing hormone-releasing hormone binding sites in cultured porcine lymphocytes
22. Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor
23. Cloning, sequencing, and expression of human gonadotropin-releasing hormone (GnRH) receptor
24. Cloning and characterization of the human gonadotropin-releasing hormone receptor
25. The nucleotide sequence of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary
26. Functional domains of the gonadotropin-releasing hormone receptor
27. The gonadotropin-releasing hormone receptor: Structural determinations and regulatory control
28. The gene encoding the ovine gonadotropin-releasing hormone (GnRH) receptor: Cloning and initial characterization
29. Heterotrimeric G proteins: Organizers of transmembrane signals
30. Dimerization of cell surface receptors in signal transduction
31. Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11
32. Regulation of gonadotropin-releasing hormone and its receptor gene expression by 17beta-estradiol in cultured human granulosaluteal cells
33. Stimulation of mitogen-activated protein kinase by gonadotropin-releasing hormone in human granulosa-luteal cells
34. Hormonal regulation of estrogen receptor alpha and beta gene expression in human granulosa-luteal cells in vitro
35. Presence and characteristics of receptors for [D- Trp6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer
36. Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium
37. Gonadotrophin releasing hormone (GnRH) receptor and steroid receptors in human uterine leiomyoma, myometrium and endometrium
38. Gene expression of gonadotropin-releasing hormone, but not its receptor, in human endometrium and decidua
39. Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle
40. Human oviductal gonadotropin-releasing hormone: Possible implications in fertilization, early embryonic development, and implantation
41. Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate
42. The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer
43. LHRH receptors in the human pancreas. Basis for antihormonal treatment in ductal carcinoma of the pancreas
44. Characterization of binding sites for a GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters
45. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: Evidence for an autocrine-inhibitory LHRH loop
46. Growth inhibition of human prostatic cancer cells by an agonist of gonadotropin-releasing hormone
47. GnRH - Mechanisms of action
48. Gonadotropin-releasing hormone receptors in gynecological tumors
49. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium
50. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma
51. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines
52. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines
53. Characteristics and distribution of receptors for [D-Trp6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor and sex steroids in 500 biopsy samples of human breast cancer
54. Gonadotropin-releasing hormone gene expression in MDA-MB-231 and ZR-75-71 breast carcinoma cell lines
55. Presence of gonadotropin-releasing hormone and his messenger ribunucleic acid in human ovarian epithelial carcinoma
56. Expression of luteinizing hormone-releasing hormone and its mRNA in human endometrial cancer cell lines
57. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone
58. Growth of human breast cancer cells inhibited by luteinizing hormone-releasing hormone agonist
59. Involvement of annexin V in antiproliferative effects of gonadotropin-releasing hormone agonists on human endometrial cancer cell line
60. Growth-inhibitory actions of analogues of luteinizing hormone releasing hormone on tumor cells
61. Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75
62. Lupron retards proliferation of ovarian tumor cells cultured in serum-free medium
63. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis
64. Effect of gonadotropin releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor-positive human cancer cell lines
65. Effects of GnRH analogs on six ovarian cancer cell lines in culture
66. Inhibition of growth of human ovarian cancer in nude mice by luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75)
67. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer and its relevance as an autocrine growth factor
68. Treatment of ovarian cancer with LHRH antagonists
69. Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth
70. Luteinizing hormone releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
71. Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II
72. Effects of LHRH agonists on the growth of human prostatic tumor cells: 'In vitro' and 'in vivo' studies
73. The effects of gonadotropin-releasing hormone analogues in prostate cancer are mediated through specific tumor receptors
74. Luteinizing hormone-releasing hormone (LHRH) might act as a negative autocrine regulator of proliferation of human ovarian cancer
75. Luteinizing hormone-releasing hormone as an autocrine growth factor in ES-2 ovarian cancer cell line
76. Luteinizing hormone-releasing hormone agonist triptorelin antagonizes signal transduction and mitogenic activity of epidermal growth factor in human ovarian and endometrial cancer cell lines
77. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145
78. Treatment with luteinizing hormone-releasing hormone antagonist SB-75 decreases levels of epidermal growth factor receptor and its mRNA in OV-1063 human epithelial ovarian cancer xenografts in nude mice
79. Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell lines
80. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation of tyrosine residues of specific substrates in various tumors
81. Regulation of luteinizing hormone-releasing hormone receptor binding by heterologous receptor-stimulated tyrosine phosphorylation
82. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin like growth factors
83. Evidence for coupling of phosphotyrosine phosphatase to gonadotropin-releasing hormone receptor in ovarian carcinoma membrane
84. Phosphotyrosine phosphatase activity in membranes from endometrial carcinoma
85. Coupling of gonadotropin releasing hormone receptor to Gi protein in human reproductive tract tumors
86. Antiproliferative signaling of LHRH in human endometrial and ovarian cancer cells through G-protein αi-mediated activation of phosphotyrosine phosphatase
87. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling
88. Luteinizing hormone-releasing hormone (LHRH) agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers
89. Luteinizing hormone-releasing hormone agonists interfere with mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells
90. Effects of Asn87 and Asp318 mutations on ligand binding and signal transduction in the rat GnRH receptor
91. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor
92. Identification of N-glycosylation sites in the gonadotropin-releasing homone receptor: Role in receptor expression but not ligand binding
93. The human gonadotropin-releasing hormone receptor gene: Complete structure including multiple promotors, transcription initiation sites, and polyadenylation signals
94. Direct G-protein activation of ion channels?
95. Malignant transformation by G protein-coupled hormone receptors
96. Structure and function of G protein-coupled receptors
97. Tissue-specific pattern of variant transcripts of the human gonadotropin-releasing hormone receptor gene
98. Frequent expression of Fas in gonadotropin-releasing hormone receptor-bearing tumors
99. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulate Fas ligand expression in reproductive tumors: Possible mechanism for hormonal control of apoptotic cell death
100. Fas and Fas-ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells
101. Luteinizing hormone-releasing hormone induces nuclear factor kappaB-activation and inhibits apoptosis in ovarian cancer cells
102. Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by LHRH agonist triptorelin
103. Involvement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase in α1B-adrenergic receptor/Gαq-induced inhibition of cell proliferation
104. Differentially regulated immediate early genes in the rat uterus
105. Regulation of UT-OC-3 ovarian carcinoma cells by cytokines: Inhibitory effects on cell proliferation and activation of transcription factors AP-1 and NF-κB
106. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells
107. Identification of the second gonadotropin-releasing hormone in chicken hypothalamus: Evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hormones in avian species
108. Primary structure and biological activity of a third gonadotropin-releasing hormone from lamprey brain
109. Second gene for gonadotropin-releasing hormone in humans
110. Regional expression of mRNA encoding a second form of gonadotropin-releasing hormone in the macaque brain
111. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells
112. A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates
113. Distinct efficacies for two endogenous ligands on a single cognate gonadoliberin receptor
114. Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian gonadotropin-releasing hormone receptor in cell surface expression, ligand binding, and receptor phosphorylation and internalization
115. A chicken gonadotropin-releasing hormone receptor that confers agonist activity to mammalian antagonists. Identification of D-Lys(6) in the ligand and extracellular loop two of the receptor as determinants
116. Establishment of immunological probes to study human gonadotropin-releasing hormone receptors